Даваа–Баасан 08:30–20:00 · Бямба 09:00–16:00
Now showing 1 - 4 of 4
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Visual Outcomes Following Traumatic Cataract Surgery in Children in Mongolia: Experience Over 2 Years at a Major Hospital
    (Mongolian National University of Medical Sciences, 2021-09-21) ;
    Battsetseg Baljinnyam
    ;
    ;
    Nasantogtokh Erdenebileg
    ;
    Objective: To describe the demographics, nature of the injury and visual outcomes of pediatric patients presenting with traumatic cataract requiring surgery at the National Center for Maternal and Child Health in Mongolia and to compare the relevant literature on traumatic pediatric cataracts in other countries. Methods: The charts of individuals aged ≤ 18 years who underwent surgery for traumatic cataract over a two-year period at a pediatric hospital were reviewed. The data collected included: demographic information, mode and time of injury, intraocular lens type, surgeries pre- and post-operative best-corrected visual acuity, and surgical complications. Results: Over the 2-year study period, 27 children underwent cataract surgery for traumatic cataract. The mean age was 8.52 ± 4.7 years (range, 1-17 years). The type of primary insult was penetrating injury in over 80% of patients. The mean interval between injury and cataract surgery was 7 ± 6.5months. Pre-cataract surgery no patient had vision better than 20/40; after cataract surgery 36% had 20/50. Conclusion: A better understanding of the causes of eye injuries and the environments in which they occur can provide informed educated strategies for parents, caregivers, and teachers and can possibly reduce time to treatment.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Trifocal Intraocular Lens Implantation to Treat Visual Demands in Mongolian Patients
    (Mongolian National University of Medical Sciences, 2022-04-01) ; ;
    Objective: Intraocular lens (IOL) implants are artificial lenses which helps to clear up the vision after cataract surgery. In this work, we aimed to compare the monofocal and trifocal IOL implantation during phacoemulsification. Methods: 60 eyes of 60 patients were divided into 2 equal groups. Postoperative astigmatism and UCVA were measured and compared during week 1, week 2 and month. Results: The mean preoperative UCVA was 6.83 ± 4.61 in the monofocal IOL group, and 17.5 ± 17.55 in the trifocal IOL group. At the first week: The mean postoperative UCVA at one week was 35.46 ± 19.45 and 58.64 ± 20.77, in each group respectively. The mean postoperative BCVA in the first week was 42.71 ± 20.63 and 65.91 ± 20.85, in each group respectively. The mean postoperative UCVA at 1 month was 46.57 ± 24.37 and 76.36 ± 23.61, in each group, while BCVA was 63.14 ± 24.94 and 89.54 ± 14.63. There was a highly significant statistical difference between the result of UCVA preoperative and the results of UCVA at the early and last postoperative follow up. Conclusion: From our results, it is evident that post-operative near UCVA and BCVA was statistically significant at monofocal and trifocal groups.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Bevacizumab Monotherapy or Combined with Laser versus Laser Monotherapy in Mongolian Patients with Diabetic Macular Edema
    (Mongolian National University of Medical Sciences, 2016-06-25)
    Anaraa Toishubai
    ;
    ;
    Baasankhuu Jamyanjav
    ;
    Sun Taek Lim
    ;
    Objectives: To evaluate the efficacy and safety of bevacizumab monotherapy and bevacizumab therapy combined with laser therapy versus laser monotherapy in Mongolian patients with visual impairment due to diabetic macular edema (DME). Methods: One hundred twelve eligible patients, aged ^18 years, with type 1 or 2 diabetes mellitus and best corrected visual acuity (BCVA) in the study eye of 35 to 69 Early Treatment Diabetic Retinopathy Study letters at 4 m (Snellen equivalent: >6/60 or <6/12), and with visual impairment due to center-involved DME were included in the study. Patients were randomized into three treatment groups: (1) intravitreal bevacizumab monotherapy (n = 42), (2) intravitreal bevacizumab combined with laser therapy (n = 35), and (3) laser monotherapy (n = 35). Bevacizumab injections were given for three initial monthly doses and then pro re nata thereafter based on BCVA stability and DME progression. The primary efficacy endpoints were the mean change in BCVA and central retinal subfield thickness from baseline to month 12. Results: Bevacizumab monotherapy and bevacizumab + laser were superior to laser monotherapy in improving the mean change in BCVA letter score from baseline to month 12 (+8.3 and +11.3 vs +1.1 letters; both p ><0.0001). At month 12, a greater proportion of patients gained >10 and >15 letters and had a BCVA letter score >73 (Snellen equivalent: >6/12) with bevacizumab monotherapy (23.8% and 7.1% and 4.8%, respectively) and bevacizumab + laser (57.1% and 28.6% and 14.3%, respectively) versus laser monotherapy (0% and 0% and 0%, respectively). The mean central retinal subfield thickness was significantly reduced from baseline to month 12 with bevacizumab (-124.4 pm) and bevacizumab + laser (-129.0 pm) versus laser (-62.0 pm; both p = 0.002). Conjunctival hemorrhage was the most common ocular event. No endophthalmitis cases occurred. Conclusion: Bevacizumab monotherapy or bevacizumab + laser showed superior BCVA improvements over macular laser treatment alone in Mongolian patients with visual impairment due to DME.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Comparison of Iris Calved IOL and LASIK Surgery Outcome in Mongolian Patients
    (Mongolian National University of Medical Sciences, 2022-06-30) ;
    Batochir Soningerel
    ;
    Objective: There are significantly few studies which have introduced the comparison intra ocular lens (IOL) outcome with conventional phacoemulsification surgery. Thus, in the present study, we aimed to compare anterior chamber intra ocular lens (AC IOL) and LASIK surgery in Mongolian patients. Methods: This study was conducted on 67 participants. Females comprised 58.8 % in the IOL patients and 72.0 % in the LASIK groups. The mean age of the participants was 32.06 ± 9.29 in IOL and 29.4 ± 6.59 in the LASIK group. Results: Pre operative uncorrected visual activity (UCVA) was 7.94 ± 6.56 in IOL patients, and 2 weeks after surgery, UCVA had increased to 61.18 ± 21.18. In the case of LASIK, pre-operative UCVA was 20.56 ± 17.20, and the value was 86.8 ± 18.23 after surgery. Pre-operative best-corrected visual acuity (BCVA) IOL and LASIK group were 37.65 ± 18.38 and 97.6 ± 4.31, respectively. However, only IOL patients had significantly improved BCVA after surgery (71.76 ± 22.97 at post-operative 2nd week). Conclusions: The best-corrected visual acuity and was better for AC IOL than LASIK surgery.